CPC A61K 31/495 (2013.01) [A61K 31/4184 (2013.01); A61K 31/437 (2013.01); A61K 31/4523 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01)] | 13 Claims |
1. A composition in solid unit dosage form comprising:
(a) the compound PAC-1:
![]() and
(b) at least one second active agent, wherein the at least one second active agent is an inhibitor of a mutant kinase, and the at least one second agent is osimertinib.
|